The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the months of October / November 2021. Please extend your congratulations to the following individuals.
October 2021
Monica Lemmon (Neurology) received an award from Child Neurology Foundation Award in the amount of $30,000 for a project entitled, Decision Aid for Infants with Neurology Conditions. The project period is 10/01/2021-09/30/2023.
Lars Wagner (Hematology-Oncology) received an award from Atrium Health in the amount of $7,000 for a project entitled, Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine. The project period is 12/01/2021 – 07/03/2023.
November 2021
Samia Aleem (Neonatology) received an award from Airway Therapeutics for $95,573 for a project entitled, Safety and Tolerability of AT-100 (RHSP-D) in Preterm Neonates at High Risk for Development of Bronchopulmonary Dysplasia. The project period is 10/27/2021-09/30/2022.
Stephen Balevic (Rheumatology) received an award from Childhood Arthritis & Rheumatology Research Alliance for $49,140 for a project entitled, CARRA-Arthritis Foundation Small Grant. The project period is 07/01/2021-06/30/2023.
Michael Freemark (Endocrinology) and Elizabeth Greene received an award from Lawson Wilkins Pediatric Endocrine Society in the amount of $50,000 for a project entitled, Effects of Metformin on Influenza Outcomes. The project period is 07/01/2021-06/30/2022.
Rasheed Gbadegesin (Nephrology) received an award from Travera Therapeutics in the amount $194,558 for a project entitled, A Phase Open-Label Single-Arm Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Sparsentan Treatment in Pediatric Subjects with Selected Proteinuric Glomerular Diseases. The project period is 11/18/2021-10/31/2023.
Dwight Koeberl (Medical Genetics) received an award from Moderna Therapeutics in the amount of $829,267 for a project entitled, A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the MRNA-3927-P101 Study. The project period is 11/01/2021-10/31/2029.
Andrew Landstrom (Cardiology) received an award from the University of British Columbia/Heart and Stroke Foundation of Canada in the amount of $150 (per patient) for a project entitled, Implantable Cardioverter Defibrillator Therapy in Catecholaminergic Ventricular. The project period is 11/22/2021-06/30/2022.
Andrew Landstrom (Cardiology) received an award from the University of British Columbia/Heart and Stroke Foundation of Canada in the amount of $300 (per patient+$940 for startup cost) for a project entitled, Improving Diagnosis and Treatment in CPVT. The project period is 11/22/2021-06/30/2022.
Corrine Linardic (Hematology-Oncology) received an award from Public Health Institute in the amount of $7,834 for a project entitled, Study Chair: COG NCTN Network Group Operations Center. The project period is 03/01/2021-02/28/2022.
Corrine Linardic (Hematology-Oncology) received an award from Public Health Institute in the amount of $15,665 for a project entitled, Committee Leadership: COG NCTN Network Group Operations Center. The project period is 03/01/2021-02/28/2022.
Marie McDonald (Medical Genetics) received an award from Genzyme Corporation in the amount of $75,000 for a project entitled, Residency in Medical Genetics at Duke University. The project period is 07/26/2021-06/30/2024.
William Steinbach (Infectious Diseases) received an award from Sfunga Therapeutics in the amount of $94,990 for a project entitled, Expanded Pre-Clinical Aspergillosis Experimental Plan for Sfu-AM-2-19. The project period is 11/01/2021-06/01/2022.
Muhammad Zafar (Neurology) received an award from Neurocrine Biosciences in the amount of $177,992 for a project entitled, A Phase 2 Multicenter Randomized Double-blind Placebo-Controlled Parallel Group Study to Assess the Efficacy Safety Tolerability and Pharmacokinetics of NBI - 827104 in Pediatric Subjects with Epileptic Encephalopathy with Continuous Spike and Wave During Sleep. The project period is TBD.
Congratulations to these faculty on their awards and best wishes to them in their investigative work.
William J. Steinbach, MD
Vice Chair, Research
Samuel L. Katz Distinguished Professor of Pediatrics
Division of Infectious Diseases
Interim Chief, Division of Transplant and Cellular Therapy
Professor in Molecular Genetics and Microbiology